Risk versus risk: decision-making dilemmas of drug regulation in the United States and Germany.
Daemmrich
A
A
Chemical Heritage Foundation, 315 Chestnut Street, Philadelphia, PA 19106, USA. arthurd@chemheritage.org
Krucken
G
G
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy*; D019380:Anti-HIV Agents; D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000331:legislation & jurisprudence* / Q000458:organization & administration*; D015507:Drugs, Investigational / Q000627:therapeutic use*; D005858:Germany; D033161:Government Regulation; D006801:Humans; D007880:Legislation, Drug; D010358:Patient Participation; D011056:Political Systems; D011057:Politics; D011639:Public Opinion; D012306:Risk; D012941:Social Responsibility; D013792:Thalidomide / Q000009:adverse effects / Q000627:therapeutic use; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D015507:Drugs, Investigational; D013792:Thalidomide